Ernexa Therapeutics Inc. Indefinite-lived Intangible Assets (Excluding Goodwill)
Ernexa Therapeutics Inc. (ERNA) had Indefinite-lived Intangible Assets (Excluding Goodwill) of $0 as of 2022-12-31, per its 10-K filed 2024-03-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill · last filed 2024-03-14
- 2022-12-31: Indefinite-lived Intangible Assets (Excluding Goodwill) $0.00.
- 2022-09-30: Indefinite-lived Intangible Assets (Excluding Goodwill) $0.00.
- 2022-06-30: Indefinite-lived Intangible Assets (Excluding Goodwill) $0.00.
- 2022-03-31: Indefinite-lived Intangible Assets (Excluding Goodwill) $5.99M.
| Period end | Indefinite-lived Intangible Assets (Excluding Goodwill) | Indefinite-lived Intangible Assets (Excluding Goodwill) as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $5.99M 10-Q · filed 2022-07-01 | |
| 2021-12-31 | $5.99M 10-K · filed 2023-03-20 | $6.86M 10-K · filed 2022-04-15 |
| 2021-09-30 | $5.99M 10-K/A · filed 2022-07-01 | $6.86M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $5.99M 10-K/A · filed 2022-07-01 | $6.86M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $5.99M 10-K/A · filed 2022-07-01 | $6.86M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $5.99M 10-K/A · filed 2022-07-01 | $6.86M 10-Q · filed 2021-05-17 |
| 2020-09-30 | $5.99M 10-K/A · filed 2022-07-01 | |
| 2020-06-30 | $5.99M 10-K/A · filed 2022-07-01 | |
| 2018-12-31 | $6.00M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |